LOADING
Comparing Merck & Company (MRK) and Comcast Corporation (CMCSA) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CMCSA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $356.0B | $76.5B |
| P/E Ratio | 114.5 | 6.9 |
| Forward P/E | 15.3 | 5.9 |
| PEG Ratio | 2.71 | 2.39 |
| EPS | $1.26 | $3.12 |
| Revenue Growth (YoY) | 5.1% | -1.2% |
| Profit Margin | 4.8% | 9.0% |
| Return on Equity | 7.0% | 11.5% |
| Dividend Yield | 2.31% | 6.08% |
| Beta | 0.23 | 0.66 |
| 52-Week High | $156.00 | $32.05 |
| 52-Week Low | $79.67 | $21.28 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Comcast Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Comcast Corporation offers a higher dividend yield for income investors. Comcast Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.